Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity
- PMID: 32849620
- PMCID: PMC7417361
- DOI: 10.3389/fimmu.2020.01741
Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity
Abstract
The development of autoimmunity involves complex interactions between genetics and environmental triggers. The gut microbiota is an important environmental constituent that can heavily influence both local and systemic immune reactivity through distinct mechanisms. It is therefore a relevant environmental trigger or amplifier to consider in autoimmunity. This review will examine recent evidence for an association between intestinal dysbiosis and autoimmune diseases, and the mechanisms by which the gut microbiota may contribute to autoimmune activation. We will specifically focus on recent studies connecting tryptophan metabolism to autoimmune disease pathogenesis and discuss evidence for a microbial origin. This will be discussed in the context of our current understanding of how tryptophan metabolites regulate immune responses, and how it may, or may not, be applicable to autoimmunity.
Keywords: autoimmunity; dysbiosis; kynurenine; metabolites; microbiota; tryptophan.
Copyright © 2020 Brown, Robusto and Morel.
Figures
Similar articles
-
Intestinal dysbiosis and probiotic applications in autoimmune diseases.Immunology. 2017 Sep;152(1):1-12. doi: 10.1111/imm.12765. Epub 2017 Jun 29. Immunology. 2017. PMID: 28556916 Free PMC article. Review.
-
Psychological Stress, Intestinal Barrier Dysfunctions, and Autoimmune Disorders: An Overview.Front Immunol. 2020 Aug 25;11:1823. doi: 10.3389/fimmu.2020.01823. eCollection 2020. Front Immunol. 2020. PMID: 32983091 Free PMC article. Review.
-
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.J Autoimmun. 2018 Aug;92:12-34. doi: 10.1016/j.jaut.2018.05.008. Epub 2018 Jun 1. J Autoimmun. 2018. PMID: 29861127 Review.
-
Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases.Front Immunol. 2020 Oct 28;11:573079. doi: 10.3389/fimmu.2020.573079. eCollection 2020. Front Immunol. 2020. PMID: 33193357 Free PMC article. Review.
-
Gut microbiota in autoimmunity: potential for clinical applications.Arch Pharm Res. 2016 Nov;39(11):1565-1576. doi: 10.1007/s12272-016-0796-7. Epub 2016 Jul 22. Arch Pharm Res. 2016. PMID: 27444041 Review.
Cited by
-
Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications.Gut Microbes. 2024 Jan-Dec;16(1):2401654. doi: 10.1080/19490976.2024.2401654. Epub 2024 Oct 18. Gut Microbes. 2024. PMID: 39420751 Free PMC article. Review.
-
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.Signal Transduct Target Ther. 2024 Oct 4;9(1):263. doi: 10.1038/s41392-024-01952-8. Signal Transduct Target Ther. 2024. PMID: 39362875 Free PMC article. Review.
-
Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet.Immunol Rev. 2024 Aug;325(1):131-151. doi: 10.1111/imr.13343. Epub 2024 May 8. Immunol Rev. 2024. PMID: 38717158 Review.
-
When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.Front Immunol. 2024 Feb 15;15:1339971. doi: 10.3389/fimmu.2024.1339971. eCollection 2024. Front Immunol. 2024. PMID: 38426096 Free PMC article. Review.
-
Interplay between Microbiota and γδ T Cells: Insights into Immune Homeostasis and Neuro-Immune Interactions.Int J Mol Sci. 2024 Feb 1;25(3):1747. doi: 10.3390/ijms25031747. Int J Mol Sci. 2024. PMID: 38339023 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical